<DOC>
	<DOCNO>NCT01256190</DOCNO>
	<brief_summary>A multi-center , prospective , randomize , single-blind , control , comparative efficacy safety trial subject undergo open liver resection surgery . The study enroll 42 eligible subject conduct 4 site Netherlands .</brief_summary>
	<brief_title>A Study Fibrocaps Liver Surgery Netherlands</brief_title>
	<detailed_description>This multi-center , prospective , randomize , single-blind , control , comparative efficacy safety trial 60 subject undergoing hepatic resection . Subjects randomize 2:1 ratio Fibrocaps + Gelfoam Gelfoam day surgery . The Fibrospray device use apply Fibrocaps Target Bleeding Site . All investigator use Fibrospray device train correct safe set-up use Fibrocaps Fibrospray device prior participate clinical trial .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>1 . Male female â‰¥ 18 year age 2 . Subjects able willing provide write sign informed consent 3 . Willing use medically accept form contraception time consent completion followup study visit 4 . Has life expectancy least one year 5 . Presence mild moderate bleeding/oozing control conventional surgical technique include limited suture , ligature , cautery ineffective impractical 1 . Pregnant lactate woman 2 . Has know intolerance blood product Fibrocaps component 3 . Unwilling receive human blood product 4 . Subject know allergy porcine gelatin 5 . Has mental physical condition would , opinion Investigator , place subject unacceptable risk render subject unable meet requirement protocol 6 . Currently participate participate another clinical study involve another investigational agent within 4 week plan date surgery , plan participation another clinical trial 4 week surgery 7 . Has clinicallysignificant coagulation disorder may interfere assessment efficacy pose safety risk subject accord Investigator 8 . Platelets ( PLT ) &lt; 100 x109 PLT/L screen 9 . Activated Partial Thromboplastin Time ( aPTT ) &gt; 100 second screen 10. International Normalized Ratio ( INR ) &gt; 2.5 screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>